Sahar Naderi, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 3
Offices
3 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Naderi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A136408 · Current
Licensed to practise in California · since 2015 · expires 2027-05-31 · Baylor College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,264
Medicare paid this office $1,264 for 37 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 20 | $186 | $7 |
Who their Medicare patients are
37 Original Medicare patients in 2024. Average age 71 · Women 51% · Also on Medicaid 68% · Health risk score 1.96. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 73% · Diabetes 46% · Heart failure 35% · Atrial fibrillation 32% · Coronary heart disease 30% · Chronic kidney disease 30%.
The office billed $10,803, Medicare allowed $2,457 and paid $1,264; for 47 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 37 | 47 | 71 | 1.96 | $10,803 | $1,264 |
| 2023 | 50 | 71 | 70 | 2.00 | $10,034 | $1,968 |
| 2022 | 41 | 58 | 69 | 1.87 | $8,489 | $1,771 |
| 2021 | 18 | 22 | 66 | 2.11 | $1,961 | $453 |
| 2020 | 33 | 54 | 67 | 3.46 | $7,028 | $1,464 |
| 2019 | 33 | 56 | 70 | 2.29 | $8,535 | $1,765 |
| 2018 | 48 | 69 | 67 | 2.15 | $7,604 | $1,768 |
| 2017 | 688 | 979 | 74 | 2.03 | $142,051 | $35,044 |
| 2016 | 830 | 1,259 | 73 | 2.08 | $203,316 | $49,184 |
| 2015 | 441 | 633 | 72 | 1.86 | $75,848 | $19,270 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $223 | $6 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $198 | $7 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $112 | $7 |
2020: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $237 | $8 |
2019: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $175 | $8 |
2018: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 28 | $287 | $7 |
2017: 12 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 464 | $3,962 | $7 |
| Long return visit (40+ min) | 32 | $3,785 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,653 | $122 |
| Return visit (30+ min) | 38 | $2,737 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,332 | $65 |
| Long return visit (40+ min) | 25 | $2,304 | $77 |
| Return visit (30+ min) | 21 | $1,895 | $63 |
| New patient visit (45+ min) | 18 | $1,842 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,537 | $35 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,524 | $66 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,339 | $122 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 52 | $1,264 | $24 |
2016: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $5,337 | $64 |
| Long return visit (40+ min) | 42 | $4,848 | $91 |
| Long return visit (40+ min) | 40 | $4,820 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 493 | $4,460 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,766 | $121 |
| New patient visit (45+ min) | 24 | $2,655 | $111 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 104 | $2,542 | $24 |
| Return visit (30+ min) | 24 | $2,523 | $70 |
| New patient visit (60+ min) | 22 | $2,455 | $112 |
| New patient visit (45+ min) | 20 | $2,307 | $115 |
| Return visit (30+ min) | 27 | $2,031 | $66 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,578 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,221 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,204 | $93 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $981 | $82 |
| Short return visit (20+ min) | 11 | $593 | $46 |
| Short return visit (20+ min) | 12 | $501 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $265 | $24 |
2015: 4 services
| New patient visit (60+ min) | 60 | $8,913 | $149 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 349 | $3,815 | $8 |
| Long return visit (40+ min) | 30 | $3,685 | $100 |
| New patient visit (45+ min) | 16 | $1,738 | $109 |
Medicaid work
$9,628 in 2024
Medicaid paid $9,628 for 384 billed services this clinician did in 2024, up to 75 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $4,752 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 322 | $4,139 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 50 | $736 |
| 2024 | 384 | 3 | 75 | $9,628 |
| 2023 | 170 | 1 | 26 | $380 |
| 2022 | 159 | 1 | 26 | $895 |
| 2021 | 83 | 1 | 31 | $717 |
| 2020 | 63 | 1 | 14 | $314 |
| 2019 | 46 | 1 | 16 | $182 |
| 2018 | 52 | 1 | 19 | $146 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 170 | $380 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 159 | $895 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 83 | $717 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 63 | $314 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 46 | $182 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 52 | $146 |
Drugs they prescribed that Part D paid
$71,636
Pharmacies billed $71,636 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 620) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
547 generic and 73 brand-name prescriptions · $71,636 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 29 | $36,066 | $1,244 |
| Jardiance | 25 | $13,068 | $523 |
| Nebivolol | 18 | $2,540 | $141 |
| Ranolazine Er | 16 | $936 | $59 |
| Carvedilol | 55 | $605 | $11 |
See all 19 drugs
| Entresto | 29 | $36,066 | $1,244 |
| Jardiance | 25 | $13,068 | $523 |
| Nebivolol | 18 | $2,540 | $141 |
| Ranolazine Er | 16 | $936 | $59 |
| Carvedilol | 55 | $605 | $11 |
| Metoprolol | 57 | $580 | $10 |
| Amlodipine Besylate | 43 | $551 | $13 |
| Losartan | 47 | $513 | $11 |
| Torsemide | 16 | $442 | $28 |
| Metoprolol | 37 | $411 | $11 |
| Atorvastatin | 33 | $367 | $11 |
| Isosorbide Mononitrate Er | 25 | $324 | $13 |
| Rosuvastatin | 27 | $263 | $10 |
| Spironolactone | 27 | $258 | $10 |
| Hydralazine | 12 | $255 | $21 |
| Atenolol | 16 | $213 | $13 |
| Lisinopril | 11 | $170 | $15 |
| Furosemide | 16 | $163 | $10 |
| Nitroglycerin | 12 | $159 | $13 |
Year by year
| 2024 | 620 | 122 | 0% (0) | 12% | $71,636 |
| 2023 | 529 | 100 | 0% (0) | 12% | $53,272 |
| 2022 | 351 | 88 | 0% (0) | 15% | $18,719 |
| 2021 | 253 | 66 | 0% (0) | 10% | $6,570 |
| 2020 | 345 | 81 | 0% (0) | 11% | $20,196 |
| 2019 | 250 | 61 | 0% (0) | 18% | $10,946 |
| 2018 | 423 | 109 | 0% (0) | 26% | $24,623 |
| 2017 | 908 | 132 | None | 13% | $35,125 |
| 2016 | 620 | 113 | 0% (0) | 13% | $37,398 |
| 2015 | 124 | 37 | 0% (0) | 19% | $38,029 |
| 2014 | 76 | 16 | 0% (0) | None | $17,538 |
| 2013 | 54 | 12 | 0% (0) | None | $1,116 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Entresto | 20 | $24,365 | $1,218 |
| Jardiance | 22 | $13,855 | $630 |
| Ranolazine Er | 16 | $1,004 | $63 |
| Amlodipine Besylate | 38 | $561 | $15 |
| Metoprolol | 50 | $524 | $10 |
| Carvedilol | 45 | $521 | $12 |
| Metoprolol | 39 | $469 | $12 |
| Atorvastatin | 33 | $459 | $14 |
| Losartan | 40 | $438 | $11 |
| Torsemide | 17 | $340 | $20 |
| Nitroglycerin | 21 | $337 | $16 |
| Rosuvastatin | 22 | $317 | $14 |
| Lisinopril | 16 | $252 | $16 |
| Isosorbide Mononitrate Er | 21 | $248 | $12 |
| Furosemide | 20 | $234 | $12 |
| Atenolol | 13 | $174 | $13 |
2022: 12 drugs
| Nebivolol | 11 | $458 | $42 |
| Carvedilol | 34 | $403 | $12 |
| Metoprolol | 36 | $362 | $10 |
| Isosorbide Mononitrate Er | 32 | $344 | $11 |
| Atorvastatin | 24 | $341 | $14 |
| Hydralazine | 12 | $290 | $24 |
| Furosemide | 21 | $258 | $12 |
| Metoprolol | 19 | $249 | $13 |
| Lisinopril | 15 | $243 | $16 |
| Amlodipine Besylate | 21 | $230 | $11 |
| Losartan | 14 | $172 | $12 |
| Nitroglycerin | 11 | $149 | $14 |
2021: 9 drugs
| Atorvastatin | 29 | $379 | $13 |
| Metoprolol | 31 | $330 | $11 |
| Carvedilol | 25 | $301 | $12 |
| Isosorbide Mononitrate Er | 23 | $260 | $11 |
| Metoprolol | 12 | $227 | $19 |
| Atenolol | 20 | $198 | $10 |
| Lisinopril | 11 | $190 | $17 |
| Furosemide | 18 | $183 | $10 |
| Losartan | 11 | $155 | $14 |
2020: 11 drugs
| Metoprolol | 32 | $644 | $20 |
| Atorvastatin | 40 | $635 | $16 |
| Metoprolol | 29 | $331 | $11 |
| Carvedilol | 25 | $331 | $13 |
| Ezetimibe | 14 | $320 | $23 |
| Furosemide | 23 | $257 | $11 |
| Lisinopril | 22 | $239 | $11 |
| Isosorbide Mononitrate Er | 23 | $224 | $10 |
| Atenolol | 18 | $193 | $11 |
| Amlodipine Besylate | 14 | $165 | $12 |
| Spironolactone | 13 | $136 | $10 |
2019: 10 drugs
| Atorvastatin | 43 | $1,106 | $26 |
| Metoprolol | 23 | $678 | $29 |
| Metoprolol | 30 | $297 | $10 |
| Atenolol | 11 | $179 | $16 |
| Lisinopril | 19 | $177 | $9 |
| Furosemide | 14 | $163 | $12 |
| Carvedilol | 13 | $162 | $12 |
| Losartan | 11 | $161 | $15 |
| Amlodipine Besylate | 14 | $153 | $11 |
| Isosorbide Mononitrate Er | 17 | $142 | $8 |
2018: 14 drugs
| Eliquis | 16 | $6,353 | $397 |
| Pradaxa | 15 | $5,268 | $351 |
| Atorvastatin | 65 | $1,198 | $18 |
| Metoprolol | 23 | $862 | $37 |
| Rosuvastatin | 16 | $290 | $18 |
| Amlodipine Besylate | 31 | $283 | $9 |
| Metoprolol | 32 | $278 | $9 |
| Lisinopril | 22 | $250 | $11 |
| Losartan | 16 | $248 | $15 |
| Clopidogrel | 13 | $224 | $17 |
| Isosorbide Mononitrate Er | 23 | $218 | $9 |
| Atenolol | 13 | $192 | $15 |
| Furosemide | 28 | $171 | $6 |
| Carvedilol | 13 | $116 | $9 |
2017: 20 drugs
| Eliquis | 11 | $4,550 | $414 |
| Pradaxa | 11 | $4,428 | $403 |
| Ezetimibe | 17 | $2,074 | $122 |
| Atorvastatin | 94 | $1,341 | $14 |
| Klor-Con 8 | 14 | $1,092 | $78 |
| Metoprolol | 30 | $832 | $28 |
| Potassium Chloride | 22 | $770 | $35 |
| Metoprolol | 81 | $744 | $9 |
| Propranolol Hcl Er | 12 | $657 | $55 |
| Carvedilol | 67 | $484 | $7 |
| Clopidogrel | 52 | $450 | $9 |
| Amlodipine Besylate | 83 | $447 | $5 |
| Rosuvastatin | 27 | $446 | $17 |
| Isosorbide Mononitrate Er | 40 | $418 | $10 |
| Lisinopril | 41 | $328 | $8 |
| Losartan | 42 | $323 | $8 |
| Propafenone | 14 | $249 | $18 |
| Furosemide | 51 | $217 | $4 |
| Spironolactone | 12 | $135 | $11 |
| Hydrochlorothiazide | 24 | $94 | $4 |
2016: 14 drugs
| Diltiazem 24hr Er | 20 | $4,330 | $216 |
| Labetalol | 18 | $1,035 | $58 |
| Atorvastatin | 49 | $950 | $19 |
| Carvedilol | 54 | $462 | $9 |
| Amlodipine Besylate | 75 | $425 | $6 |
| Metoprolol | 66 | $319 | $5 |
| Propafenone | 12 | $303 | $25 |
| Nitrostat | 12 | $296 | $25 |
| Isosorbide Mononitrate Er | 26 | $273 | $11 |
| Clopidogrel | 22 | $262 | $12 |
| Losartan | 31 | $244 | $8 |
| Lisinopril | 33 | $203 | $6 |
| Furosemide | 31 | $174 | $6 |
| Spironolactone | 17 | $114 | $7 |
2015: 5 drugs
| Stribild | 13 | $34,229 | $2,633 |
| Losartan | 13 | $196 | $15 |
| Atorvastatin | 11 | $177 | $16 |
| Carvedilol | 16 | $118 | $7 |
| Amlodipine Besylate | 11 | $54 | $5 |
2014: 3 drugs
| Clopidogrel | 16 | $118 | $7 |
| Atenolol | 12 | $24 | $2 |
| Lisinopril | 12 | $24 | $2 |
Money from drug and device companies
$16 in 2019
A payment is not proof that care is biased.
| Avion Pharmaceuticals | Prenate Mini | $16 | 1 payment
|
See the published payment
| Avion Pharmaceuticals | Meals · 2019-06-19 | Prenate Mini | $16 |
Professional record
- NPI
- 1013183334
- Licence
- CA A136408, NC 149017California A136408: Current · expires 2027-05-31
- Trained
- Baylor College of Medicine, 2008
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 2 Bon Air Rd Ste 100, Larkspur, CA, 94939
- NPI first listed
- 2008-05-06
- NPI last updated
- 2026-05-18
- NPI record certified
- 2026-05-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.